Keith A. Meister bought $13.8M of GeneDx (WGS)
Executed May 13, disclosed May 15, 2 days later.
Over the 21 trading sessions from the disclosed entry session (May 15), the stock returned +58.0% (delay-adjusted); from the execution session (May 13), +58.2%. Derived: entry at the session's open, exit at the close 20 sessions later.
Keith A. Meister (Director) filed 11 Form 4 reports in the trailing twelve months (4 purchases, 7 sales), most often in Illumina, Inc. (ILMN). Across 4 priced purchase filings, the average 21-session return was +22.8% from execution and +20.9% from disclosure (delay-adjusted; derived). The largest single filing was $148.2M of ILMN (741,127 sh across 14 lots, as filed), executed Aug 4.
Healthcare · GeneDx Holdings Corp., a genomics company, provides genetic testing services
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→1,204,615 sh across 12 lots
Exec May 7
Filed May 11 · 9:21 PM ET WGSPURCHASE GeneDx Holdings Corp. $13.3M
167,847 sh across 6 lots
Exec Mar 3
Filed Mar 5 · 7:19 PM ET WGSPURCHASE GeneDx Holdings Corp. $5.6M
100,000 sh across 3 lots
Exec May 8 2025
Filed May 12 2025 · 5:30 PM ET